Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..
about
HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesCIViC databaseHyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.p16, HPV, and Cetuximab: What Is the Evidence?Safety of drug treatments for head and neck cancer.Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents.Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.Treatment de-intensification strategies for head and neck cancer.[Association of HPV infection, p16 status, and efficacy of radiotherapy with or without cetuximab in advanced oropharyngeal squamous cell carcinoma].Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer.E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.Head and neck cancer in 2016: A watershed year for improvements in treatment?Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study.Human papilloma virus: An etiological and prognostic factor for oral cancer?Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.Head and neck cancer in Hong Kong.Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab.Cavernous sinus involvement in human papillomavirus associated oropharyngeal squamous cell carcinoma: case report of an atypical site of distant metastasis.Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality ApproachesMachine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges
P2860
Q26752584-F5674F42-7B45-4CCB-A034-D41527EB0232Q27612411-8828270B-BEBA-484D-8A8F-3F3416ECAB6FQ30313175-8A3D5648-59B1-4CB9-A945-5C21D251C53EQ30373904-B4FB1E1F-4118-4273-9BFE-7386E173B591Q34544410-D992BF47-918D-4F0B-AA7B-1CDD5898E688Q36238876-87713296-5F15-4159-887D-EDB40A0EA089Q38672321-D3CD111F-9FA7-49CD-9048-ADE183CFB85AQ38773776-B27B1748-B899-4A08-890B-6675540B9AF0Q38809582-C2BD44CA-F1B5-4E31-ABED-EB9DA635D727Q38959371-067C3BEC-8973-4FDB-8233-05CDDC060F39Q38971558-0E757AC7-7120-425C-83F5-67473DC34732Q38971561-AE07BBDE-3C9A-43D5-8C83-94F29C124908Q38984523-1D95257A-E61D-404F-95E1-839E7139C437Q40498986-056BD437-5947-4775-B70D-749B1DACB97DQ41278675-165DA8A6-AB16-40EB-AD02-F33FA7D12E0FQ43041829-4E336FCE-3437-4B96-B6F8-280E2747DE36Q44786676-C58AE20D-D693-4ED7-BC81-2E5D031B079AQ46048688-5ACAAE78-4FF0-41E4-8522-B63082AB9A00Q46738588-45CCFC99-6F81-4358-BCE0-19B875E94003Q47288168-F60B6399-E5DF-44BD-A36E-8B965CB34670Q47555534-5782F90A-8243-4959-AF91-14B31322ABE1Q49896415-7F97C51B-D390-48B5-98C8-DEA46DD6A635Q49960053-FB3C2963-873C-47A8-A675-077E5A36C053Q50602051-3328AD7E-4484-43ED-9C3E-6579CA4D9FFDQ55036229-A35C1F02-FE8E-4FC9-9FEA-66B763B81DCAQ55246604-27D1A393-30DF-4438-B1BD-577D29A39FBCQ57816910-09994A02-9A2F-4314-AF21-40380E42508EQ58769400-D846ECB3-B939-4356-89D3-EBE1EAE505C2
P2860
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Association of Human Papilloma ...... d With Radiotherapy With or ..
@ast
Association of Human Papilloma ...... d With Radiotherapy With or ..
@en
Association of Human Papilloma ...... With Radiotherapy With or ...
@nl
type
label
Association of Human Papilloma ...... d With Radiotherapy With or ..
@ast
Association of Human Papilloma ...... d With Radiotherapy With or ..
@en
Association of Human Papilloma ...... With Radiotherapy With or ...
@nl
prefLabel
Association of Human Papilloma ...... d With Radiotherapy With or ..
@ast
Association of Human Papilloma ...... d With Radiotherapy With or ..
@en
Association of Human Papilloma ...... With Radiotherapy With or ...
@nl
P2093
P2860
P921
P3181
P356
P1476
Association of Human Papilloma ...... rapy With or Without Cetuximab
@en
P2093
David Raben
Diana Bell
James A Bonner
Jeltje Schulten
Jordi Giralt
Kian K Ang
Paul M Harari
P2860
P304
P3181
P356
10.1200/JCO.2015.62.5970
P407
P577
2016-04-20T00:00:00Z